Quotient Sciences Supports Crinetics Pharmaceuticals with Fully Integrated Pediatric Development and Clinical Testing Program
Crinetics Pharmaceuticals, a pharmaceutical company that develops therapies for rare endocrine diseases, and Quotient Sciences, a drug development and manufacturing accelerator, have announced a partnership to support Crinetics’ CRN04894 pediatric program. The partnership will utilize Quotient Sciences’ unique Translational Pharmaceutics® platform to
External URL: https://www.quotientsciences.com/news/crinetics-pharmaceuticals-pediatric-development-program/
By Arcinova
478 Views
Recent Posts
- Explore the Impact of Verifying Carbon Capture Technologies
- ITS wins Supplier of the Year at the ISPE UK Affiliate Annual Awards
- Cembre MG4 | The Newest Thermal Printer for Identification & Labelling | Available From Thorne & Derrick
- Share your expertise at ICPVT15: International Conference on Pressure Vessel Technology
- Minimising GWR Probe Build Up with the Magnetrol Eclipse 706
Back to News >
Share this
Most Recent Post
© Copyright. North East of England Process Industry Cluster (NEPIC) 2015
Built by iTCHYROBOT